Predictive Value of Clinical Judgment of Tumour Progression in Phase II Trials

par Kotecki, Nuria, Penel, Nicolas, Adenis, Antoine, Ferte, Charles, Clisant, Stéphanie
Publié 2012

Frequency of Certain Established Risk Factors in Soft Tissue Sarcomas in Adults: A Prospective Descriptive Study of 658 Cases

par Penel, Nicolas, Grosjean, Jessica, Robin, Yves Marie, Vanseymortier, Luc, Clisant, Stéphanie, Adenis, Antoine
Publié 2008

Improvement of the initial management of sarcomas after the dissemination of evidence-based guidelines depends on the primary sarcoma location: a population-based study

par Ligier, Karine, Maynou, Carlos, Leroy, Xavier, Robin, Yves-Marie, Martin, Philippe, Clisant, Stéphanie, Richard, Florence, Penel, Nicolas
Publié dans BMC Cancer (2015)

Determinants of patient delay in doctor consultation in head and neck cancers (Protocol DEREDIA)

par Christophe, Véronique, Leroy, Tanguy, Seillier, Mélanie, Duthilleul, Camille, Julieron, Morbize, Clisant, Stéphanie, Foncel, Jérôme, Vallet, Fanny, Lefebvre, Jean-Louis
Publié 2014

Clinical complete responders to definite chemoradiation or radiation therapy for oesophageal cancer: predictors of outcome

par Adenis, Antoine, Tresch, Emmanuelle, Dewas, Sylvain, Romano, Olivier, Messager, Mathieu, Amela, Eric, Clisant, Stéphanie, Kramar, Andrew, Mariette, Christophe, Mirabel, Xavier
Publié 2013

Megestrol acetate versus metronomic cyclophosphamide in patients having exhausted all effective therapies under standard care

par Penel, N, Clisant, S, Dansin, E, Desauw, C, Dégardin, M, Mortier, L, Vanhuyse, M, Bonodeau, F, Fournier, C, Cazin, J-L, Adenis, A
Publié 2010

Impact of early palliative care on overall survival of patients with metastatic upper gastrointestinal cancers treated with first-line chemotherapy: a randomised phase III trial

par Hutt, Emilie, Da Silva, Arlette, Bogart, Emilie, Le Lay-Diomande, Sara, Pannier, Diane, Delaine-Clisant, Stéphanie, Le Deley, Marie-Cécile, Adenis, Antoine
Publié dans BMJ Open (2018)

Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trial

par Brodowicz, Thomas, Liegl-Atzwager, Bernadette, Tresch, Emmanuelle, Taieb, Sophie, Kramar, Andrew, Gruenwald, Viktor, Vanseymortier, Marie, Clisant, Stéphanie, Blay, Jean-Yves, Le Cesne, Axel, Penel, Nicolas
Publié dans BMC Cancer (2015)

Circulating vascular endothelial growth factor (VEGF) as predictive factor of progression-free survival in patients with advanced chordoma receiving sorafenib: an analysis from a p...

par Lebellec, Loic, Bertucci, François, Tresch-Bruneel, Emmanuelle, Bompas, Emmanuelle, Toiron, Yves, Camoin, Luc, Mir, Olivier, Laurence, Valerie, Clisant, Stephanie, Decoupigny, Emilie, Blay, Jean-Yves, Goncalves, Anthony, Penel, Nicolas
Publié dans Oncotarget (2016)

Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial

par Pannier, Diane, Adenis, Antoine, Bogart, Emilie, Dansin, Eric, Clisant-Delaine, Stéphanie, Decoupigny, Emilie, Lesoin, Anne, Amela, Eric, Ducornet, Sandrine, Meurant, Jean-Pierre, Le Deley, Marie-Cécile, Penel, Nicolas
Publié dans BMC Cancer (2018)

The FREGAT biobank: a clinico-biological database dedicated to esophageal and gastric cancers

par Mariette, Christophe, Renaud, Florence, Piessen, Guillaume, Gele, Patrick, Copin, Marie-Christine, Leteurtre, Emmanuelle, Delaeter, Christine, Dib, Malek, Clisant, Stéphanie, Harter, Valentin, Bonnetain, Franck, Duhamel, Alain, Christophe, Véronique, Adenis, Antoine
Publié dans BMC Cancer (2018)

A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted olid tumours

par Adenis, A, Ray-Coquard, I, Italiano, A, Chauzit, E, Bui-Nguyen, B, Blay, J-Y, Tresch-Bruneel, E, Fournier, C, Clisant, S, Amela, E Y, Cassier, P A, Molimard, M, Penel, N
Publié 2013

Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter stu...

par Adenis, Antoine, de la Fouchardiere, Christelle, Paule, Bernard, Burtin, Pascal, Tougeron, David, Wallet, Jennifer, Dourthe, Louis-Marie, Etienne, Pierre-Luc, Mineur, Laurent, Clisant, Stéphanie, Phelip, Jean-Marc, Kramar, Andrew, Andre, Thierry
Publié dans BMC Cancer (2016)

Erratum to: Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a mul...

par Adenis, Antoine, de la Fouchardiere, Christelle, Paule, Bernard, Burtin, Pascal, Tougeron, David, Wallet, Jennifer, Dourthe, Louis-Marie, Etienne, Pierre-Luc, Mineur, Laurent, Clisant, Stéphanie, Phelip, Jean-Marc, Kramar, Andrew, Andre, Thierry
Publié dans BMC Cancer (2016)

Preoperative chemoradiation with paclitaxel-carboplatin or with fluorouracil-oxaliplatin—folinic acid (FOLFOX) for resectable esophageal and junctional cancer: the PROTECT-1402, ra...

par Messager, Mathieu, Mirabel, Xavier, Tresch, Emmanuelle, Paumier, Amaury, Vendrely, Véronique, Dahan, Laetitia, Glehen, Olivier, Vasseur, Frederique, Lacornerie, Thomas, Piessen, Guillaume, El Hajbi, Farid, Robb, William B., Clisant, Stéphanie, Kramar, Andrew, Mariette, Christophe, Adenis, Antoine
Publié dans BMC Cancer (2016)

Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)(†)

par Bompas, E., Le Cesne, A., Tresch-Bruneel, E., Lebellec, L., Laurence, V., Collard, O., Saada-Bouzid, E., Isambert, N., Blay, J. Y., Amela, E. Y., Salas, S., Chevreau, C., Bertucci, F., Italiano, A., Clisant, S., Penel, N.
Publié dans Ann Oncol (2015)

REGOSARC: Regorafenib versus placebo in doxorubicin‐refractory soft‐tissue sarcoma—A quality‐adjusted time without symptoms of progression or toxicity analysis

par Berry, Vincent, Basson, Laurent, Bogart, Emilie, Mir, Olivier, Blay, Jean‐Yves, Italiano, Antoine, Bertucci, François, Chevreau, Christine, Clisant‐Delaine, Stéphanie, Liegl‐Antzager, Bernadette, Tresch‐Bruneel, Emmanuelle, Wallet, Jennifer, Taieb, Sophie, Decoupigny, Emilie, Le Cesne, Axel, Brodowicz, Thomas, Penel, Nicolas
Publié dans Cancer (2017)

Sorafenib for Patients with Advanced Angiosarcoma: A Phase II Trial from the French Sarcoma Group (GSF/GETO)

par Ray-Coquard, Isabelle, Italiano, Antoine, Bompas, Emmanuelle, Le Cesne, Axel, Robin, Yves-Marie, Chevreau, Christine, Bay, Jacques-Olivier, Bousquet, Guilhem, Piperno-Neumann, Sophie, Isambert, Nicolas, Lemaitre, Laurent, Fournier, Charles, Gauthier, Eric, Collard, Olivier, Cupissol, Didier, Clisant, Stéphanie, Blay, Jean-Yves, Penel, Nicolas
Publié 2012

The ongoing French metastatic breast cancer (MBC) cohort: the example-based methodology of the Epidemiological Strategy and Medical Economics (ESME)

par Pérol, David, Robain, Mathieu, Arveux, Patrick, Mathoulin-Pélissier, Simone, Chamorey, Emmanuel, Asselain, Bernard, Berchery, Delphine, Gourgou, Sophie, Breton, Mathias, Delaine-Clisant, Stéphanie, Mons, Muriel, Diéras, Véronique, Carton, Matthieu, Guizard, Anne-Valérie, Laborde, Lilian, Laurent, Carine, Loeb, Agnès, Mouret-Reynier, Marie-Ange, Parent, Damien, Perrocheau, Geneviève, Campion, Loïc, Velten, Michel, Cailliot, Christian, Ezzalfani, Monia, Simon, Gaëtane
Publié dans BMJ Open (2019)